Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,375 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled Trial.
Seo YD, Lu H, Black G, Smythe K, Yu Y, Hsu C, Ng J, Hermida de Viveiros P, Warren EH, Schroeder BA, O'Malley RB, Cranmer LD, Loggers ET, Wagner MJ, Bonham L, Pillarisetty VG, Kane G, Berglund P, Hsu FJ, Mi X, Alexiev BA, Pierce RH, Riddell SR, Jones RL, Ter Meulen J, Kim EY, Pollack SM. Seo YD, et al. Among authors: jones rl. JAMA Oncol. 2023 Dec 1;9(12):1660-1668. doi: 10.1001/jamaoncol.2023.4015. JAMA Oncol. 2023. PMID: 37824131 Free PMC article. Clinical Trial.
Immune-based therapies for sarcoma.
Pollack SM, Loggers ET, Rodler ET, Yee C, Jones RL. Pollack SM, et al. Among authors: jones rl. Sarcoma. 2011;2011:438940. doi: 10.1155/2011/438940. Epub 2011 Jan 23. Sarcoma. 2011. PMID: 21331153 Free PMC article.
MDM2 inhibition in liposarcoma: a step in the right direction.
Constantinidou A, Pollack SM, Jones RL. Constantinidou A, et al. Among authors: jones rl. Lancet Oncol. 2012 Nov;13(11):1070-1. doi: 10.1016/S1470-2045(12)70457-6. Epub 2012 Oct 17. Lancet Oncol. 2012. PMID: 23084518 No abstract available.
Systemic therapy in primary angiosarcoma of the spleen.
Ferreira BP, Rodler ET, Loggers ET, Pollack SM, Jones RL. Ferreira BP, et al. Among authors: jones rl. Rare Tumors. 2012 Oct 10;4(4):e55. doi: 10.4081/rt.2012.e55. Epub 2012 Nov 13. Rare Tumors. 2012. PMID: 23372919 Free PMC article.
The evolution of systemic therapy in sarcoma.
Constantinidou A, Pollack S, Loggers E, Rodler E, Jones RL. Constantinidou A, et al. Among authors: jones rl. Expert Rev Anticancer Ther. 2013 Feb;13(2):211-23. doi: 10.1586/era.12.161. Expert Rev Anticancer Ther. 2013. PMID: 23406562 Review.
Management of gastrointestinal stromal tumors.
Rajendra R, Pollack SM, Jones RL. Rajendra R, et al. Among authors: jones rl. Future Oncol. 2013 Feb;9(2):193-206. doi: 10.2217/fon.12.178. Future Oncol. 2013. PMID: 23414470 Review.
Clinical benefit of trabectedin in uterine adenosarcoma.
Schroeder BA, Rodler ET, Loggers ET, Pollack SM, Jones RL. Schroeder BA, et al. Among authors: jones rl. Med Oncol. 2013 Jun;30(2):501. doi: 10.1007/s12032-013-0501-3. Epub 2013 Feb 28. Med Oncol. 2013. PMID: 23456619
1,375 results